Main Article Content
Introduction: Telemedicine interventions amongst studies showed great potential in improving gestational diabetes mellitus (GDM) management. It has facilitated and allowed the patients to get closer treatment, such as blood glucose monitoring and glycemic control. Considering current situation, further studies are required to assess the intervention effects in relation to another outcomes parameter being examined.
Objective: The aim of this systematic review is to evaluate the role of telemedicine in controlling blood glucose level of patient with GDM.
Method: A systematic review of randomized controlled trials was undertaken by searching on 5 databases. Risk of bias was assessed in selection, performance, detection, attrition, and outcome reporting using Review Manager 5.4.1 tools. We analyzed the blood glucose level as primary outcome and secondary outcomes, such as maternal and neonatal assessment and its significancy.
Result: We identified 6 randomized controlled trials studies in total. There are 830 participants with GDM recruited (443 patients as intervention groups and 387 patients as control groups). Results analysis indicate the effectiveness of telemedicine approaches to control blood glucose level in patients with GDM shows significantly in three studies included (P<0.05), also shows positive improvements in the observed secondary outcomes. We recommend further studies in larger populations where the prevalence of GDM is still high and remain unresolved. Therefore, if it is implemented properly in the future, the risk of loss of complications can be prevented.
Conclusion: The implementation of blood glucose telemonitoring can be promisingly an acceptable and effective tool for sustainable blood glucose control and its maintenance for GDM patients, especially who are facing difficulty to access conventional health care regularly.
Keywords: gestational diabetes mellitus, telemedicine, blood glucose
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
© Journal of Asian Medical Students’ Association (JAMSA). Released under a Creative Commons license.
Daley BJ, Ni’Man M, Neves MR, Bobby Huda MS, Marsh W, Fenton NE, et al. mHealth apps for gestational diabetes mellitus that provide clinical decision support or artificial intelligence: A scoping review. Diabet Med. 2022;39(1):1–16.
Reddi Rani P, Begum J. Screening and diagnosis of gestational diabetes mellitus, where do we stand. J Clin Diagnostic Res. 2016;10(4):QE01–4.
Rodriguez BSQ, Mahdy H. Gestational Diabetes. StatPearls [Internet] Treasure Isl StatPearls Publ [Internet]. 2021 Aug 25 [cited 2022 May 6]; Available from: https://www.ncbi.nlm.nih.gov/books/NBK545196/
Nguyen CL, Pham NM, Binns CW, Van Duong D, Lee AH. Prevalence of gestational diabetes mellitus in eastern and southeastern Asia: A systematic review and meta-analysis. J Diabetes Res. 2018;2018(Cc).
Xie W, Dai P, Qin Y, Wu M, Yang B, Yu X. Effectiveness of telemedicine for pregnant women with gestational diabetes mellitus: An updated meta-analysis of 32 randomized controlled trials with trial sequential analysis. BMC Pregnancy Childbirth. 2020;20(1):1–14.
Eberle C, Stichling S. Telemedical approaches to managing gestational diabetes mellitus during COVID-19: Systematic review. JMIR Pediatr Parent. 2021;4(3):1–11.
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ. 2021;372.
Al-ofi EA, Mosli HH, Ghamri KA, Ghazali SM. Management of postprandial hyperglycaemia and weight gain in women with gestational diabetes mellitus using a novel telemonitoring system. J Int Med Res. 2019;47(2):754–64.
Guo H, Zhang Y, Li P, Zhou P, Chen LM, Li SY. Evaluating the effects of mobile health intervention on weight management, glycemic control and pregnancy outcomes in patients with gestational diabetes mellitus. J Endocrinol Invest. 2019;42(6):709–14.
Mackillop L, Hirst JE, Bartlett KJ, Birks JS, Clifton L, Farmer AJ, et al. Comparing the efficacy of a mobile phone-based blood glucose management system with standard clinic care in women with gestational diabetes: Randomized controlled trial. JMIR mHealth uHealth. 2018;6(3).
Rasekaba TM, Furler J, Young D, Liew D, Gray K, Blackberry I, et al. Using technology to support care in gestational diabetes mellitus: Quantitative outcomes of an exploratory randomised control trial of adjunct telemedicine for gestational diabetes mellitus (TeleGDM). Diabetes Res Clin Pract [Internet]. 2018;142:276–85. Available from: https://doi.org/10.1016/j.diabres.2018.05.049
Rollo ME, Baldwin JN, Hutchesson M, Aguiar EJ, Wynne K, Young A, et al. The feasibility and preliminary efficacy of an ehealth lifestyle program in women with recent gestational diabetes mellitus: A pilot study. Int J Environ Res Public Health. 2020;17(19):1–24.
Tian Y, Zhang S, Huang F, Ma L. Comparing the efficacies of telemedicine and standard prenatal care on blood glucose control in women with gestational diabetes mellitus: Randomized controlled trial. JMIR mHealth uHealth. 2021;9(5):1–13.
Zheng W, Huang W, Liu C, Yan Q, Zhang L, Tian Z, et al. Weight gain after diagnosis of gestational diabetes mellitus and its association with adverse pregnancy outcomes: a cohort study. BMC Pregnancy Childbirth. 2021;21(1):1–9.
Yang Y, Wang Z, Mo M, Muyiduli X, Wang S, Li M, et al. The association of gestational diabetes mellitus with fetal birth weight. J Diabetes Complications [Internet]. 2018;32(7):635–42. Available from: https://doi.org/10.1016/j.jdiacomp.2018.04.008
Song Y, Bernard L, Jorgensen C, Dusfour G. The Challenges of Telemedicine in Rheumatology. 2021;8(October):1–7.